The global mRNA Flu Vaccine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “mRNA Flu Vaccine Industry Forecast” looks at past sales and reviews total world mRNA Flu Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected mRNA Flu Vaccine sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global mRNA Flu Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyzes the strategies of leading global companies with a focus on mRNA Flu Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global mRNA Flu Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Flu Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Flu Vaccine.

Segmentation by Type:

• mRNA-1010
• mRNA-1020
• mRNA-1030

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

Americas

• United States
• Canada
• Mexico
• Brazil

APAC

• China
• Japan
• Korea
• Southeast Asia
• India
• Australia

Europe

• Germany
• France
• UK
• Italy
• Russia

Middle East & Africa

• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Company's Coverage:

• Moderna
• BioNTech
• CureVac
• Novavax
• Sanofi
• Inovio Pharmaceuticals
• Arcturus Therapeutics Holdings
• eTheRNA immunotherapies
• Valneva
• Vaxart
• Entos Pharmaceuticals
• Abnova Corporation
• Anima Biotech
• Sarepta Therapeutics
• iBio
• Barinthus Biotherapeutics
• Alnylam Pharmaceuticals
• Beam Therapeutics

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global mRNA Flu Vaccine market?
2. What factors are driving mRNA Flu Vaccine market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do mRNA Flu Vaccine market opportunities vary by end market size?
5. How does mRNA Flu Vaccine break out by Type, by Application?